β-lactamase production in Provotella and in vitro susceptibilities to selected β-lactam antibiotics

International Journal of Antimicrobial Agents

Volumn 21, Issue 3, 2003, Pages 267-273

  Dubreuil, L ^a   Behra Miellet, J ^a   Vouillot, C ^a   Bland, S ^b   Sedallian, A ^b   Mory, F ^b  

^a UNIV LILLE   (France)

^b NONE

Author keywords

lactamase production; Antibiotic resistance; Provotella

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALOTIN; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; TICARCILLIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DILUTION; ENZYME ACTIVITY; ENZYME SYNTHESIS; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROVOTELLA;

ANTI-BACTERIAL AGENTS; BACTEROIDACEAE INFECTIONS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVOTELLA; PREVOTELLA INTERMEDIA; PREVOTELLA MELANINOGENICA;

EID: 0037334102     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00352-7     Document Type: Article

References (25)

1. Dubreuil L., Singer E., Jaulhac B., et al. Sensibilité des anaérobies stricts aux antibiotiques. Antibiotiques. 1:1999;147-153.
2. King A., Downes J., Nord C.E., Phillips I. Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe. Clin. Microbiol. Infect. 5:1999;404-416.
3. Brook I., Calhoum L., Yocum P. β-lactamase-producing isolates of Bacteroides species from children. Antimicrob. Agents Chemother. 18:1980;164-166.
4. Heimdahl A., von Konow L., Nord C.E. β-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy. J. Antimicrob. Chemother. 8:1981;225-229.
5. Tuner K., Nord C.E. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand. J. Inf. Dis. 39:(suppl):1983;83-85.
6. Nyfors S., Kononen E., Takala A., Joussimies Somer H. β-lactamase production of oral anaerobic gram-negative species in infants in relation to previous antimicrobial therapy. Antimicrob. Agents Chemother. 43:1999;1591-1594.
7. Valle G., Quiros L.M., Andres M.T., Fierro J.F. A β-lactamase belonging to group 2e from oral clinical isolates of Provotella intermedia. FEMS Microbiol. Lett. 158:1998;191-194.
8. Madinier I., Fosse T., Giudicelli J., Labia R. Cloning and biochemical characterization of a class A β-lactamase from Provotella intermedia. Antimicrob. Agents Chemother. 45:2001;2386-2389.
9. Summanen P., Baron E.J., Citron D.M., Strong C.A., Wexler H.M., Finegold S.M. Advanced identification method. Summanen P.E., Baron C., Strong H., Wexler H.M., Finegold S.M. Wadworth anaerobic bacteriology manua. 5th ed. 1993;49-79 Star Publishing Company, Belmont, California.
10. Kononen E., Eerola E., Frandsen E.V.G., Matto J., Salmenlinna S., Jousimies-Somer H. Phylogenetic characterization and proposal of a new pigmented species to the genus Provotella:Provotella pallens sp.nov. Int. J. Syst. Bacteriol. 48:1998;47-51.
11. Könonem E., Mätto J., Väisanem E., et al. Biochemical and genetic characterization of a Provotella intermedia/nigrescens like organism. Int. J. Syst. Bacteriol. 48:1998;39-46.
12. Appelbaum P.C., Spangler S.K., Jacobs M.R. Evaluation of two methods for reading testing for β-lactamase production in Bacteroides and Fusobacterium. Eur. J. Clin. Inf. Dis. 9:1990;47-50.
13. National Committee for Clinical Laboratory Standards 1997. Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard-fourth edition. NCCLS publication M11-A4. National Committee for Clinical Laboratory Standards, Villanova, PA.
14. Soussy C.J., Carret G., Cavallo J.D., et al. Antibiogram committee of the French microbiology society. report 2000-2001. Pathol. Biol. 48:2000;832-871.
15. Sedallian A., Roudon T. Activité in vitro de l'association amoxicilline-acide clavulanique sur les bactéries anaérobies. Pathol. Biol. 36:1988;678-681.
16. Appelbaum P.E., Philippon A., Jacobs M.C., Spangler S.R., Gutmann L. Characterization of beta lactamase from non Bacteroides fragilis group, Bacteroides spp and their role in beta lactam resistance. Antimicrob. Agents Chemother. 39:1990;2169-2176.
17. Grollier G., Mory F., Quentin C., et al. Survey of anaerobic susceptibility patterns: a French multicentric study. Pathol. Biol. 42:1994;498-504.
18. Mory F., Lozniewski A., Bland S., et al. Survey of anaerobic susceptibility patterns: a French multicentric study. Int. J. Antimicrob. Agents. 10:1998;229-236.
19. Fosse T., Madinier I., Hitzig C., Charbit Y. Prevalence of β-lactamase-producing strains among 149 anaerobic gram-negative rods isolated from periodontal pockets. Oral Microbiol. Immunol. 14:1999;352-357.
20. Matto J., Asikainen S., Vaisanen M.L., et al. Beta-lactamase production in Provotella intermedia, Provotella nigrescens, and Provotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents. Antimicrob. Agents Chemother. 43:1999;2383-2388.
21. Kononen E., Nyfors S., Matto J., Asikainen S., Joussimies S. β-lactamase production by oral pigmented Provotella species isolated from young children. Clin. Infect. Dis. 25:(suppl 2):1997;S272-S274.
22. Goldstein EJC, Conrad G, Citron DM. Comparative in vitro activity of gemifloxacin against aerobic and anaerobic pathogens isolated from antral sinus punctures from patients with sinusitis. International Symposium on New Quinolones. Edinburgh, 2001. Abstract 23.
23. Felmingham D, Robbins MJ, Mathias I, Tsa N, Baker I, Dalhoff A. In vitro activity of faropenem, an oral penem. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, 2000. Abstract 361.
24. Spangler SK, Jacobs MR, Appelbaum PC. Activity of WY-49605 compared with that of amoxicillin, amoxicillin/clavulanate, ciprofloxacin, cefaclor, cefpodoxime and cefuroxime against 384 anaerobic bacteria. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Orlando, 1994. Abstract 137.
25. Goldstein E.J.C., Citron D.M., Merriam C.V., Warren Y., Tyrrel K. Activity of telithromycin (HMR3647, RU66647) compared with those of erythromycin, azithromycin, clarithromycin, roxithromycin and other antimicrobial agents against unusual anaerobes. Antimicrob. Agents Chemother. 43:1999;2801-2805.